Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Priority to UY27534ApriorityCriticalpatent/UY27534A1/en
Publication of UY27534A1publicationCriticalpatent/UY27534A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Derivados de amida de ácido antranílico de la fórmula HI: donde R1 representa H o alquilo inferior, R2 H o alquilo inferior, R3 perfluoralquilo inferior, y X es O ó S, o un N-óxido o un tautómero de los mismos, a sales de estas amidas de ácido antranílico, sus N-óxidos y sus tautómeros; útiles en el tratamiento en especial de enfermedad neoplástica, tal como enfermedad tumoral, de retinopatía o degeneración macular relacionada con la edad, proceso para su preparación y uso del mismo - solo o en combinación con uno o más compuestos farmacéuticamente activos diferentes para fabricar una preparación farmacéutica para tratamiento e enfermedades referidas.Anthranilic acid amide derivatives of the formula HI: wherein R1 represents H or lower alkyl, R2 H or lower alkyl, R3 perfluoralkyl lower, and X is O or S, or an N-oxide or tautomer thereof, to salts of these anthranilic acid amides, their N-oxides and their tautomers; useful in the treatment especially of neoplastic disease, such as tumor disease, retinopathy or age-related macular degeneration, process for its preparation and use thereof - alone or in combination with one or more different pharmaceutically active compounds to manufacture a preparation Pharmaceutical for treatment and referred diseases.
UY27534A2002-11-082002-11-08
AMIDAS OF ANTRANILIC ACID AND PHARMACOLOGICAL USE OF THE SAME.
UY27534A1
(en)
New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimers disease
DERIVATIVES OF NAFTILSULPHONIC ACID, AS GLUCOSE ABSORPTION AGONISTS, A PROCESS FOR THEIR PREPARATION; A PHARMACEUTICAL COMPOSITION AND THE USE OF SUCH DERIVATIVES FOR THE PREPARATION OF A MEDICINAL PRODUCT.